Pseudoflavonifractor Species Test · Stool

Your gut holds trillions of bacteria, and not all of them are household names. Pseudoflavonifractor is one of the quieter residents, still earning its place in the medical literature, but it keeps turning up in research on metabolism, mental health, and how your body handles plant compounds from food. Knowing whether this group shows up in your stool, and how its numbers move over time, gives you a data point most routine gut testing does not cover.

This is a research stage marker, not a diagnosis. Standardized cutpoints do not yet exist, and the clinical picture is unusual: in some studies higher levels track with better metabolic health, while in others they track with worse outcomes. If you track microbiome patterns as part of a broader health picture, this number is worth having in your own baseline.

What Pseudoflavonifractor Actually Is

Pseudoflavonifractor is a genus of anaerobic bacteria that lives in the large intestine. These microbes do not produce a hormone or a protein your body directly uses. Instead, they are part of the community that breaks down fibers and plant chemicals from your diet, and a stool test measures their relative abundance among all the other bacteria present.

A closely related group called Flavonifractor sits next to Pseudoflavonifractor on the bacterial family tree. Much of the published research technically studies Flavonifractor, particularly the species Flavonifractor plautii, which is known for breaking down flavonoids (the colorful plant compounds in berries, tea, and vegetables). Findings from Flavonifractor research are often cited in Pseudoflavonifractor discussions, but they are not the same organism. When research points specifically to one genus rather than the other, this article says so.

What Its Abundance Reflects

Pseudoflavonifractor is not a direct physiological measurement like blood pressure or blood sugar. Its abundance reflects the shape of your gut community and how that community metabolizes certain compounds. Research suggests this bacterial group contributes to pathways involved in amino acid synthesis and flavonoid breakdown, which may shape signals that reach your bloodstream, liver, and brain.

Because it shifts with diet, medications, and environment, its relative abundance is best understood as one small window into your microbiome's overall function rather than a standalone indicator of health or disease.

Metabolic Health and Diabetes

The strongest signal in the current literature ties this bacterial family to metabolic biology, but the findings point in different directions depending on the population. Research specifically measuring Pseudoflavonifractor has flagged it as one of three potential microbial biomarkers linked to obesity driven type 2 diabetes progression, though the sample was small. Research on the related Flavonifractor genus shows a different pattern: Flavonifractor plautii was enriched in people with normal blood sugar compared with those with prediabetes in a study spanning populations in India and Denmark, and it was more abundant in healthy infants than in infants who later went on to develop type 1 diabetes.

What this means for you: if you are tracking microbiome markers as part of a metabolic workup, treat Pseudoflavonifractor as one input among many rather than a standalone risk signal. Pair it with blood sugar, insulin, triglycerides, and a broader microbial picture to make any meaningful interpretation.

Mental Health and Stress Response

Several studies link the Flavonifractor family to mood and stress related outcomes. Flavonifractor plautii appeared among the top bacterial species predicting worse post traumatic neuropsychiatric outcomes such as PTSD (post traumatic stress disorder), depression, and persistent physical symptoms in trauma exposed adults. Separate work in adults with newly diagnosed bipolar disorder found a higher prevalence of Flavonifractor compared with healthy controls, and affective disorders in general are associated with a higher prevalence of Flavonifractor alongside a lower abundance of the health linked Christensenellaceae family.

These findings come from the related Flavonifractor genus rather than Pseudoflavonifractor specifically, and they are associations, not proof that the bacteria are causing the symptoms. They do suggest the family deserves attention in the ongoing conversation about gut brain biology.

Colorectal Cancer and Gut Inflammation

Flavonifractor plautii was associated with colorectal cancer in a study of Indian patients, where researchers suggested that aggressive breakdown of protective flavonoids from the diet might contribute to disease progression. A separate large study of young onset colorectal cancer in 1,238 participants identified gut microbiota biomarkers that could distinguish patients from healthy controls, with microbial species serving as candidates for non invasive detection.

Ulcerative colitis research has also flagged microbial species in the Pseudoflavonifractor and Flavonifractor family as ecologically important. One study in 287 patients found that microbial species and gut microbial endotypes were better predictors of clinical remission on anti TNF (tumor necrosis factor) or anti integrin biologics than clinical variables alone.

Kidney Injury

A Mendelian randomization and case control study on acute kidney injury reported that the genus Flavonifractor was associated with reduced risk of acute kidney injury. Mendelian randomization uses inherited genetic variants as a stand in for long term exposure, which helps separate correlation from likely causation. The result is preliminary and is based on the Flavonifractor genus rather than Pseudoflavonifractor specifically, but it fits the pattern of this bacterial family appearing more abundant in healthier people across several different conditions.

Why the Evidence Points in Opposite Directions

You just read that higher levels in this bacterial family have been linked to both better metabolic health and kidney resilience, and to worse PTSD, depression, and bipolar disorder outcomes. That is not a contradiction so much as a signal that this is not a simple "good number, bad number" marker. It behaves more like a fingerprint of your overall microbial community and diet. The same bacterial family can appear as a favorable signature in one context (for example, a fiber and flavonoid rich diet supporting metabolic health) and as part of a dysbiotic pattern in another (for example, a community shift that tracks with chronic stress or inflammation). The right interpretation depends on what else is moving alongside it in the same stool sample, not on the Pseudoflavonifractor number alone.

Reference Ranges

Pseudoflavonifractor is an exploratory research marker. No national or international guideline body has published clinical cutpoints for this genus, and published studies report relative abundance differences rather than universal thresholds. Different stool testing methods (16S rRNA sequencing, shotgun metagenomics, qPCR) produce numbers on different scales and are not directly comparable. Your lab's result is most useful as a baseline to track against your own future samples from the same lab using the same method, rather than as a number to compare against a population norm.

Tracking Your Trend

A single stool sample is a snapshot of a constantly shifting community. Gut bacterial abundances fluctuate with your last few meals, recent antibiotic or medication use, travel, illness, and stress. One reading of Pseudoflavonifractor cannot tell you whether your gut is on a good or bad trajectory. A trend can.

A reasonable cadence is a baseline now, a retest three to six months after any meaningful change (a new diet, a course of antibiotics, a new probiotic or fiber regimen, a weight loss protocol), and at least one retest per year if you are tracking gut health proactively. Always use the same lab and the same assay method across tests, since different platforms can produce dramatically different numbers for the same sample.

What to Do With an Unusual Result

A Pseudoflavonifractor result on its own should not drive a clinical decision. What matters is the pattern in the rest of your stool panel: how much Faecalibacterium prausnitzii and Akkermansia muciniphila you carry, your short chain fatty acid levels (especially butyrate), your stool calprotectin (a marker of gut inflammation), and your pancreatic elastase (a marker of digestive enzyme output). If your Pseudoflavonifractor result looks unusual alongside a low butyrate level, elevated calprotectin, or a broader dysbiotic pattern, that combination is worth investigating with a gastroenterologist or a physician trained in microbiome interpretation. If your Pseudoflavonifractor number looks off but the rest of your stool panel and symptoms are unremarkable, retesting in a few months is usually more informative than reacting to a single reading.

When Results Can Be Misleading

• Recent antibiotics: a course of antibiotics in the weeks before sampling can dramatically reshape your gut community, and a low or high Pseudoflavonifractor reading may reflect temporary disruption rather than your baseline.
• Parkinson's device assisted therapies: in people with Parkinson's disease starting deep brain stimulation or levodopa carbidopa intestinal gel, Pseudoflavonifractor was overrepresented within two to four weeks of therapy initiation. If you recently started these therapies, your result may reflect the treatment rather than a change you can act on.
• Assay differences: different stool testing platforms measure different regions of bacterial DNA and report results in different units. A number from one lab is not directly comparable to a number from another lab.
• Recent diet changes: a sudden change in fiber, polyphenol, or processed food intake in the days before sampling can shift bacterial abundances. For the most representative result, sample during a stretch of your usual eating pattern rather than in the middle of a radical diet change.